Characterization of high-affinity binding between gangliosides and amyloid beta-protein

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Amyloid beta (A beta) protein aggregation is a hallmark of Alzheimer's disease.
• Glycosphingolipids, such as gangliosides, are abundant in neuronal membranes.
• The interaction between A beta and glycosphingolipids is not fully understood.

Purpose of the Study:

• To investigate the binding specificities of various A beta peptides and beta-APP analogues to different glycosphingolipids.
• To determine the structural requirements for A beta binding to gangliosides.

Main Methods:

• Surface Plasmon Resonance (SPR) was employed to quantify binding affinities.
• A liposome capture method was utilized to immobilize glycosphingolipids.
• A panel of A beta peptides (A beta 1-42, A beta 1-40, A beta 40-1, A beta 1-38, A beta 25-35) and beta-APP analogues were tested.

Main Results:

• A beta 1-42, A beta 40-1, A beta 1-40, and A beta 1-38 bound to GM1 ganglioside with varying affinities (A beta 1-42 > A beta 40-1 > A beta 1-40 > A beta 1-38).
• A beta 25-35 did not bind to GM1 ganglioside.
• Aged A beta derivatives exhibited higher affinity for GM1 ganglioside compared to fresh or soluble forms.
• A beta 1-40 showed differential binding to various gangliosides and neutral glycosphingolipids, with an alpha2,3NeuAc residue being crucial for binding.

Conclusions:

• Specific A beta fragments interact with gangliosides, with GM1 ganglioside being a significant binding partner.
• The presence of an alpha2,3NeuAc residue is important for A beta binding.
• Aged A beta variants demonstrate enhanced binding to GM1, potentially contributing to A beta pathology.